Sagimet Biosciences: The U.S. Acne Trial Is A Replication Exercise, Not A Discovery Bet

SGMT pivots denifanstat to acne with Phase 3 data and a funded U.S. registrational trial.

CryptoAlerta — análise de criptomoedas e mercado em tempo real